บทบาทของรังสีรักษาในมะเร็งเต้านม

Authors

  • ผศ.นพ.ศรีชัย ครุสันธิ์ ภาควิชารังสีวิทยา คณะแพทยศาสตร์ มหาวิทยาลัยขอนแก่น

Abstract

-

References

1. Friedmann AM, Tarbell NJ, Constine LS. Rhabomyosarcona. In: Halperin EC, Constine LS, Tarbell NJ Kun LE, editors. Pediatric Radiation Oncology 4th ed. Philadelphia: Lippincott Williams & Wilkins;2005. p. 319-46.

2. Breneman JC, Donaldson SS. Rhabdomyasarcoma. In: Halperin EC, Perez CA, Brady LW, editors. Perez and Brady's Principles and Practice of Radiation Oncology 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008, p. 1872-85.

3. Tsuji SY, Chan LW, Haas-Kogan DA. Pediatric (Non-CNs) Tumors. In: Hansen EK, Roach III M, editors. Handbook of Evidence-Based Radiation Oncology 2nd ed. New York: Springer: 2010. p.629-72.

4. Newton WA Jr, Gehan EA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB, et al. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an Intergroup Rhabdomyosarcoma Study. Cancer 1995;76:1073-85.

5. Maurer HM, Beltangady M, Gehan EA, Crist W, Hammond D, Hays DM, et al. The Intergroup Rhabdomyosarcoma Study-l. A final report. Cancer 1988;61:209-20.

6. Joop A. van Dongen, Adri C. Voogd, lan S Fentiman, Catherine Legrand, Richard J. Syveste David Tong, et al. Long term results of a randomized trial comparing breast conserving therapy with mastectomy: EORTC 10801 trial. J Nati Cancer Inst 2000, 92: 1143-1150.

7. Blichert-Toft M, Rose C, Andersen JA, Overgaard M. Axelsson CK, Andersen KW, et a Danish randomized trial comparting breast conservation therapy with mastectomy: sox years of life-table analysis. J Natl Cancer Inst Monogr 1992, 11: 19-25.

8. Sarrazin D. Lê MG, Arriagada R, Contesso G. Fontaine F, Spielmann M. et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer Radiother Oncol 1989; 14: 177-184.

9. Fisher B. Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N. et al. Initial results from a randomized trial evaluating lumpectomy and radiation therapy for the treatment of intraductal breast cancer, N Engl J Med 1993; 328: 1581-1586.

10. Fisher B. Dignam J, Wolmark N, Marnounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: finding from NSABP B-17. J Cin Oncol 1998; 16: 441-452.

11. Julien JP, Bijker N, Fentiman IS, Peterse JL, Delledonne V, Rouanet P, et al. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III Trial 10853. Lancet 2000; 355: 528-533.

12. Haagensen CD. Result with Halsted's radical mastectomy. In: Haagensen CD (ed) Disease of the breast, 3 rd edn. Saunder, Philadelphia, 1986: 903-932.

13. Bedwinek JM, Lee J, Fineberg BB, Ocwieza M. Incidence and sites of local failure following local therapy in patients with isolated local-regional recurrence of beast cancer. Int J Radiat Oncol Biol Phys 7: 581-585, 1981

14. Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C, Zambetti M, et al. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast cancer Res Treat 1985; 5: 95-115.

15. Fowble B, Gray R, Gilchrist K, Goodman RL, Taylor S, Tormey DC, et al: Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving chemotherapy who may benefit from post-operative radiotherapy. J clin Oncol 1988,6: 1107-1117.

16. Haagensen CD. Resul with Halsted's radical mastectomy, In: Haagensen CD, ed. Disease of the Breast, 3rd edition. Philadelphia: WB Saunder Company, 1986. 903-932.

17. Stefanik D, Goldberg R, Byrne P, Smith F, Ueno W, Smith L, et al, Local-regional failure in pailem treated with adjuvant chemolherapy for breast cancer. J Clin Oncol 1985: 3: 660-6b3.

18. Arriagada R. Le MG. Adjuvant radiotherapy in breast cancer-the treatment of lymph node arc Acta Oncol 2000; 39: 295-305.

19. Fowble B, Gray R, Gilchrist K, Goodman RL, Taylor S. Tormey DC, et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvan chemotherapy who may beneft from postoperative radiotherapy. J Clin Oncol 1988: 6: 1107-1117.

20. Fisher B, Redmond C, Fisher ER, Bauer M. Wolmark N. Wickerham DL, et al. Ten-year resuls of a randanized cliniccal trial comparing radical mastectomy and total mastectomy with or wirhout
radiation. N Engl J Med 1985:312 (11): 674-681.

21. Wallgren A, Arner O, Bergström J, Blomstedt B, Granberg PO, Räf L, et al: Radiation therapy in operable breast cancer: results from the stockholm trial on adjuvant radiotherapy. Int J Radiat
Oncol Biol Phys 1986;12 (4): 533-537.

22. Rutqvist LE, Cedermark B, Glas U, Johansson H, Rotstein S, Skoog L, el al: Radiotherapy. Chemotherapy, and Tamoxifen as adjuncts to surgery in early breast cancer: a summary of three
randamized trials. Int J Radiat Oncol Biol Phys 1989:16 (3): 629-639.

23. Overgaard M, Christensen JJ, Johansen H. Nybo-Rasmussen A, Rase C, van der Kooy P, et al: Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Bial Phys 1990; 19 (5): 1121-1124.

24. Recht A, Pierce SM, Abner A, Vicini F, Osteen RT, Love SM, et al: Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinomas. J Clin Oncol 1991 1991

25. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-681.

26. Wallgren A, Amer O, Bergström J, Blomstedt B. Granberg PO, Räf L. et al. Radiation therapy in operable broast cancer: Results from the Slockholm trial on adjuvant radiotherapy. Int J Radal Oncal Bial Phys 1986; 12: 533-537.

27. Rutgvist LE, Cedermark B, Glas U, Johansson H, Rolstein S, Skoog L. et al. Radiotherapy chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials. Int J Radiat Oncol Biol Phys 1989; 16: 629-639,

28. Overgaard M, Christensen JJ, Johansen H, Nybo-Rasmussen A, Rose C, van der Kooy P, et al. Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Biol Phys 1990; 19: 1121-1124.

29. Donegan WL, Stine SB, Samter TG. Implications of extracapsular nodal metastases for treatment and prognosis of breast cancer. Carcer 1993; 72 ; 778-782.

30. Danforth DN Jr, Findlay PA, McDonald HD, Lippman ME, Reichert CM, d'Angelo T, et al, Complete
axillary lymph node dissection for stage l-Il carcinoma of ther breast. J Clin Oncol 1986:4:655-662.

31. Handley RS: A surgeon's view of the spread of breest cancer. Cancer 1969,24: 1231-1234.

32. Perez CA, Graham ML, Taylor ME, Levy JF, Motimer LE, Philpott GW, et al. Management of Locally advanced Carcinoma of thc Breast: I. Non-Infammatory. Cancer 1994; 74: 453-465.

33. Sheldon T, Hayes DF, Cady B, Parker L, Osteen R, Silver B, et al. Primary radiation therapy for locally advanced breast cancer. Cancer 1984; 60: 1219-1225.

34. Puthawala AA, Syed AM, Sheikh KM, Gowdy RA, McNamara CS. Combincd extenal and interstitial irradiation in the treatment of stage III breast cancer. Radiology 1984; 153: 813-816.

35. Favret AM, Carlson RW, Goffinet DR, Jeffrey SS, Dirbas FM, Stockdale FE, et al. Locally advanced breast cancer: Is surgery necessary ? Breast J 2001; 7: 131-137.

36. Kirkbride P, Mackillop WJ, Priestman TJ, Browman G, Gospadarowicz M, Rousseab P, et al. The role of palliative radiotherapy for borie metastases. Can J Oncol 1996; 6 (suppl 1): 33-38.

37. Ratanatharathorn V, Powers WE, Moss WT, Perez CA.Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Oncol Biol Phys 1999; 44:1-18.

38. Nieder C, Neiwald M, Schnabel K, Berberich W. Value of surgery and radiotherapy in the treatment of brain metastases. Radiat Oncol Invest 1994; 2: 50-55.

39 Wasserman TH, Rich KM, Drzymala RE, et al. Stereotactic irradiation. In: Perez CA. Brady LW, eds. Principles and Practice of Radiation Oncology. 3rd edition. Philadelphia: Lippincott-Raven Publishers, 1998.

40. Clarke Jw, Register S, McGregor JM, Grecula JC, Mayr NA, Wang JZ, et al. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis. Am J Clin Oncol. 2010;33(1):70-74,

41. Adler JR, Cox RS, Kaplan I, Martin DP. Stereotactic radiosurgical treatment of brain metastases. J Neurosurg 1992; 76: 444-449,

42. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B. Isolated local-regional recurrence of breast cancer following mastectomy: Radiotherapeutic management. Int J Radiat Oncol Biol Phys 1990; 19: 851-858.

43. Schuck A, Nemann SK,Matthees B, RU" BE CE, Reinartz G,S Hesselmann S.et.al. Radiotherapy in the treatment of locoregional relapsesof breast cancer. The British Journal of Radiology, 75 (2002).699-E99

44. Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implication of treatment. Int J Radiat Oncol Biol Phys 1990; 19: 833-842.

45. Dalberg K, Mattsson A, Sandelin K, Rutqvist LE. Outcomc of trcatment for ipsiloateral breast tumor recurrence in early breast cancer. Breast cancer Res Treat 1998; 49: 69-78.

46. Stotter A, Kroll S, McNeese M, Holmes F, Oswald MJ, Romsdahl M. Salvage treatment of locoregional recurrence following breast conservation therapy for early breast cancer. Eur J Surg Oncol 1991:17: 231-236,

47. Radiation Treatment of Benign disease. In: Chao KSC, Perez CA, Brady LW, eds Radiation Oncology Management Decisions 2nd editian. Philadephia: Lippvicott-Williams-Wilkins 2002: 677-688.

48. Bornstein BA, Cheng CW, Rhodes LM, Rashid H, Stomper PC, Siddon RL, et al. Can simulation measurement be used to predict the irradiated lung volume in the tangential field in patients treated for breast cancer ? Int J Radiat Oncal Biol Phys 1990; 18: 181-187.

49. Kaija H, Maunu P. Tangential breast irradiation with or without internal mammary chain irradiation. Results of a randomized trial. Radiother Oncol 1995; 36: 172-176.

50. Vicini FA, Horwitz EM, Lacerna MD, Brown DM, White J, Dmuchowski CF, et al. The role of regional nodal irradiation in the management of patients with early stage breast cancer trees with breast-conseving therapy. Int J Radiat Oncol Biol Phys 1997; 39: 1069-1076,

51. Mehta K, Haffy BG. Long term outcome in patients with four or more positive lymph nodes treate with conservative surgery and radiation therapy. Int J Radiation Oncol Biol Phys 1996; 35: 679.685

52. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level l and II lymph nades is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 1992; 28A: 1415-1418.

53. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446, complete axillary dissections in patients with breast carcinoma. Cancer 1992; 69: 2496-2501.

54. Recht A, Come SE, Henderson IC, Gelman RS, Silver B, Hayes DF, et al. The sequencing of chemotherpy and radiation therapy after conserving surgery for early-stage breast cancer. NEngl J Med 1996; 334: 1356-1361

55. Walligren A, Bernier J, Gelber RD, Goldhirsch A, Roncadin M, Joseph D, et al. Timing of radiotherapy and chemotherapy following breast conserving surgery for patients with node-positive breast cancer. Int J Radiat Oncol Biol Phys 1996; 35: 649-659.

56. Recht A, Come SE, Gelman RS, Goldstein M, Tishler S, Gore SM, et al. Integration of conservation surgery, radiotherapy and chemotherapy for the treatment of early-stage node-positive breast cancer. Sequencing, timing, and outcome. J Clin Oncol 1991; 9: 1662-1667.

57. Haffty BG. Who's on first " Sequencing chemotherapy and radiation therapy in conservatively managed node-negative breast cancer. Cancer J Sci Am 1999; 5: 147-149.

58. Ahn PH, Vu HT, Lannin D, Obedian E, DiGiovanna MP, Burtness B, et al. Sequence of Radiotherapy with Tamoxifen in Conservatively Managed Breast Cancer Does Not Affect Local Relapse Rates. J Clin Oncol 2005; 23: 17-23.

59. Harris EE, Christensen VJ, Hwang WT, Fox K, Solin LJ. Impact of Concurrent Versus Sequential Tamoxifen With Radiation Therapy in Early-Stage Breast Cancer Patients Undergoing Breast Conservation Treatment. J Clin Oncol 2005; 23: 11-16.

60. Cuzick J, Stewart H, Peto R, Baum M, Fisher B, Host H, et al: Overview of randomized trial of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep1987; 71: 15-29.

61. Larson D, Weinstein M, Goldberg I, Silver B, Recht A, Cady B. et al.Edema of the arm as a funclion of the extent of axillary surgery in patients with stage I-I carcinoma of the breast trealed with primary radiotherapy. Int J Radiat Oncol Biol Phys 1988 12: 1575-1582.

62. Erickson VS, Pearson ML, Ganz PA, Adams J. Kahn KL. Arm Edema in Breast Cancer Palients. JNCI J Nati Cancer Inst 2001: 93 (2): 96-111.

63. Mariette Grobler, Rejoice Kgosana, Menzi Nsibande, Matheko Phahlamohlaka, and Peirder Selatsa. Skin care during breast radiotherapy. The south African radiographer 2010: 48(1):15-18.

64. พวงทอง ไกรพิบูลย์, วิภา บุญกิตติเจริญ, จีระภา ตันนานนท์, การักษาพยาบาลผู้ป่วยรังสี่รักษาในมะเร็งเต้านม ใน: ตำรารังสีรักษา ฟิสิกส์ ชีวรังสี การรักษาพยาบาลผู้ป่วย, พิมพ์ครั้งที่ 1, ไทยวัฒนาพานิช 2534;127-133.

Downloads

Published

2020-01-23

How to Cite

1.
ครุสันธิ์ ผ. บทบาทของรังสีรักษาในมะเร็งเต้านม. J Thai Assn of Radiat Oncol [Internet]. 2020 Jan. 23 [cited 2024 May 7];18(2):29-43. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/236632

Issue

Section

Review articles